Skip to main content

Reefer Madness 2.0: Science vs. Policy — When the Healers Speak and the Enforcers Stall

 

Tenn Canna Publishing

Reefer Madness 2.0: Science vs. Policy — When the Healers Speak and the Enforcers Stall





How HHS and FDA medical evaluations clash with DEA inaction — a modern battle of words in federal cannabis policy.

Read the series from the beginning: Reefer Madness 2.0: The War of Words Begins

HHS / FDA Scientific Findings

On August 29, 2023, the Department of Health and Human Services (HHS) submitted a scientific evaluation recommending that cannabis be rescheduled to Schedule III. The report stated:

“HHS … found that marijuana has a potential for abuse less than the drugs or other substances in Schedules I and II; that marijuana has a currently accepted medical use; and that the abuse of marijuana may lead to moderate or low physical dependence or high psychological dependence.”
— HHS Scientific Evaluation Letter to DEA, 2023

This was a clear, evidence-based recommendation supporting medical use. Modern research and decades of state legalization programs confirm these findings.

DEA / Enforcement Reality

Despite the HHS recommendations, the DEA continues to maintain that cannabis has “no currently accepted medical use,” creating a direct conflict between science and policy:

“Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis)… Schedule I drugs … are defined as drugs with no currently accepted medical use and a high potential for abuse.”
— DEA Drug Scheduling, 2025

Recent reporting highlights the ongoing stall:

“The Drug Enforcement Administration said … the marijuana rescheduling process remains stalled … despite the head of agency’s prior commitment to senators that he would prioritize the issue if confirmed for the role.”
— Marijuana Moment, 2025
“Marijuana has been ‘legalized’ and/or ‘decriminalized’ at the state level … as of January 2024 …”
— DEA 2025 National Drug Review

War of Words: Highlighting Contradictions

  • HHS: “Currently accepted medical use.”
    DEA: “No accepted medical use.”
  • HHS: “Abuse potential is lower than Schedule I/II drugs.”
    DEA: “High potential for abuse.”
  • HHS: “Rescheduling recommended.”
    DEA: “Process remains stalled.”

By letting their own words collide, the contradictions are clear — the science is settled, yet the gatekeepers remain in stasis.

Actionable Angle for Readers

  • Track official HHS/FDA reports vs. DEA statements.
  • Compare federal contradictions with real-world state legalization outcomes.
  • Document and share clear “War of Words” examples to expose the gap between evidence and enforcement.

Next in the Series

Attorney General / Executive Branch: Who has the final say on scheduling, the political leverage points, and how their statements reveal obstacles to reform.

🧭 Explore Tennessee Cannabiz Related Posts

© Tenn Canna Publishing — Reefer Madness 2.0 Series | Author: Tenn Canna Publishing

Labels:

Comments

Post a Comment

People's Choice

While Europe Forgot — Cannabis in Asia, the Middle East & Africa

Cannabis through the ages: a timeless plant woven into the spiritual, medicinal, and cultural fabric of Asia, the Middle East, and Africa.   While Europe Forgot — Cannabis in Asia, the Middle East & Africa Part 2 of the Cannabis Knowledge Restoration Project Ancient China Ancient India The Middle East Africa Archaeological Evidence The Pattern While Europe was forgetting its own cannabis knowledge — losing it to industrialization, colonialism, and eventually prohibition — other cultures were preserving theirs. Not just preserving it. Evolving it. Refining it. Passing it down through unbroken lineages of healers, physicians, and spiritual practitioners. In Post 1 , we established that cannabis was foundational to European medicine for 2,000 years — until it was deliberately erased in the 20th century. But that erasure was primarily a Western phenomenon. In China, cannabis has been documented for over 5,000 years. ...
Post a Comment
Read more

The European Foundation — Cannabis in Western Medicine & Alchemy

  Rediscovering 2,000 years of cannabis’ vital role in Western medicine — from ancient texts to Victorian royal approval. The European Foundation — Cannabis in Western Medicine & Alchemy Part 1 of the Cannabis Knowledge Restoration Project If you think cannabis is some foreign drug that showed up in the 1960s counterculture, you've been lied to. If you believe it's "alternative medicine" that real doctors would never touch, you've been lied to. If you assume your European ancestors would have been horrified by cannabis use, you've been lied to. The truth? Cannabis was foundational to Western medicine for over 2,000 years. It appears in the texts that trained every European physician from ancient Rome through the Victorian era . It was prescribed by royal doctors, documented by medieval nuns, studied by Renaissance alchemists, and listed in official pharmacopeias well into the 20th century. Prohibition didn't remove something dangerous ...
Post a Comment
Read more

Tennessee HB 1376 Explained: New Hemp-Derived Cannabinoid Laws, THCa Ban, and What Changes in 2026

  Tennessee HB 1376 ushers in a new regulatory era for hemp-derived cannabinoids , banning THCa products and placing intoxicating hemp under alcohol-style oversight in 2026. Jump Index Introduction to HB 1376 Background and Legislative History Key Provisions Definitions Regulatory Changes & Allowed Activities Prohibitions Licensing Requirements Taxes Penalties & Enforcement Impacts on Stakeholders Pros and Cons Conclusion Introduction to HB 1376 Tennessee House Bill 1376 (HB 1376), also known as Senate Bill 1413 , is a comprehensive piece of legislation enacted during the 114th General Assembly to overhaul the regulation of hemp-derived cannabinoid products (HDCPs) in the state. Signed into law by Governor Bill Lee on May 21, 2025, the bill addresses growing concerns over the unregulated sale of intoxicating hemp products, particularly those containing delta-8 THC , delta...
Post a Comment
Read more

Following the Money: Who Profits from Tennessee's Cannabis Prohibition?

  Let's examine who profits from Tennessee's current approach to cannabis. Table of Contents Introduction Private Prisons & Incarceration Economy Alcohol Industry & Hemp Takeover Law Enforcement & Asset Forfeiture TABC & Regulatory Capture Campaign Contributions & Political Reality The Cost of the System What Changed With the New Hemp Law The Missing Voice: Voters Cui Bono? Who Benefits? The Tennessee Prohibition Playbook Reform vs. Regulatory Capture What Happens Next? The Choice Before Tennessee Sources & Related Reading Following the Money: Who Profits from Tennessee's Cannabis Prohibition? A Political Economy Analysis of Cannabis Policy in Tennessee In our previous article , we demonstrated that Tennessee's neighboring states are generating hundreds of millions of dollars in tax revenue from legal cannabis markets while Tennessee pays to enforce prohibition. Illinois collected nearly $500 million...
Post a Comment
Read more

CBD Explained: What It Is, What It Does, and What It Doesn’t

  CBD, short for cannabidiol, is a naturally occurring cannabinoid found in the cannabis plant CBD Explained: What It Is, What It Does, and What It Doesn’t Separating facts from hype in the world’s most misunderstood cannabinoid CBD seems to be everywhere — oils , gummies, lotions, coffee, pet treats — yet many people are still unsure what it actually does. Let’s clear it up. What Is CBD? CBD , short for cannabidiol , is a naturally occurring cannabinoid found in the cannabis plant. Unlike THC , CBD is not intoxicating and does not produce a “high.” CBD can be extracted from both marijuana and hemp . Most commercially available CBD products are derived from hemp , which is legally defined as cannabis containing less than 0.3% delta-9-THC . How CBD Works in the Body CBD interacts with the body’s endocannabinoid system (ECS) , a regulatory network invol...
Post a Comment
Read more